Botulinum Toxin Prior Authorization Policy - Medicare Part B
Customize your policy alerts
Sign up for Providence Health Plan Policy ORPTCNEU030.0826 alerts
Get alerted when Policy ORPTCNEU030.0826 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical necessity, coverage, coding, and prior authorization for botulinum toxin products and related procedures under Medicare Part B. It applies to Providence entities and providers requesting coverage for FDA-approved and certain evaluated off-label indications.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.